{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:05:46Z","timestamp":1787969146641,"version":"build-2784847793"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1093\/humrep\/dei316","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:24:55Z","timestamp":1128644695000},"page":"429-435","source":"Crossref","is-referenced-by-count":43,"title":["Adverse effects of intradermal allogeneic lymphocyte immunotherapy: acute reactions and role of autoimmunity"],"prefix":"10.1093","volume":"21","author":[{"given":"C.","family":"Kling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Magez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kabelitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,6]]},"reference":[{"key":"key\n\t\t\t\t20171012133253_ADAMS-AND-NELSON-2004","doi-asserted-by":"crossref","unstructured":"Adams KM and Nelson JL (2004) Microchimerism: an investigative frontier in autoimmunity and transplantation. J Am Med Assoc291,1127\u20131131.","DOI":"10.1001\/jama.291.9.1127"},{"key":"key\n\t\t\t\t20171012133253_BEER-ET-AL-1981","doi-asserted-by":"crossref","unstructured":"Beer AE , Quebbeman JF, Ayers JW and Haines RF (1981) Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol141,987\u2013999.","DOI":"10.1016\/S0002-9378(16)32690-4"},{"key":"key\n\t\t\t\t20171012133253_CDC-1996","unstructured":"Centers for Disease Control (1996) Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep45,1\u201335."},{"key":"key\n\t\t\t\t20171012133253_CBER-2001","unstructured":"Center for Biologics Evaluation and Research (2001) Lymphocyte Immune Therapy. www.fda.gov\/cber\/ltr\/lit013002.htm; Access May 22, 2005."},{"key":"key\n\t\t\t\t20171012133253_CHAOUAT-2003","doi-asserted-by":"crossref","unstructured":"Chaouat G (2003) Should we re-examine the status of lymphocyte alloimmunization therapy for recurrent spontaneous abortion? Am J Reprod Immunol50,433\u2013438.","DOI":"10.1046\/j.8755-8920.2003.00132.x"},{"key":"key\n\t\t\t\t20171012133253_CHRISTIANSEN-ET-AL-1992","doi-asserted-by":"crossref","unstructured":"Christiansen OB , Christiansen BS, Husth M, Mathiesen O, Lauritsen JG and Grunnet N (1992) Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertil Steril58,328\u2013334.","DOI":"10.1016\/S0015-0282(16)55197-8"},{"key":"key\n\t\t\t\t20171012133253_CHRISTIANSEN-ET-AL-2004","doi-asserted-by":"crossref","unstructured":"Christiansen OB , Nielsen HS and Pedersen B (2004) Active or passive immunization in unexplained recurrent miscarriage. J Reprod Immunol62,41\u201352.","DOI":"10.1016\/j.jri.2003.09.003"},{"key":"key\n\t\t\t\t20171012133253_CLARK-ET-AL-2001","doi-asserted-by":"crossref","unstructured":"Clark DA , Coulam CB, Daya S and Chaouat G (2001) Unexplained sporadic and recurrent miscarrage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum Reprod Update7,501\u2013511.","DOI":"10.1093\/humupd\/7.5.501"},{"key":"key\n\t\t\t\t20171012133253_CLARKE-ET-AL-1989","doi-asserted-by":"crossref","unstructured":"Clarke JA , Hollinger FB, Lewis E, Russell LA, Miller CH, Huntley A and Flynn NM (1989) Intradermal inoculation with Heptavax-B. Immune response and histologic evaluation of injection sites. J Am Med Assoc262,2567\u20132571.","DOI":"10.1001\/jama.1989.03430180109039"},{"key":"key\n\t\t\t\t20171012133253_COMBS-ET-AL-2002","unstructured":"Combs MR , Drew MJ, Goodnough LT et al (2002) Brecher ME et al (ed), Technical Manual aaBB. American Association of Blood Banks, Bethesda, Maryland, USA."},{"key":"key\n\t\t\t\t20171012133253_COOPER-AND-STROEHLA-2003","doi-asserted-by":"crossref","unstructured":"Cooper GS and Stroehla BC (2003) The epidemiology of autoimmune diseases. Autoimmun Rev2,119\u2013125.","DOI":"10.1016\/S1568-9972(03)00006-5"},{"key":"key\n\t\t\t\t20171012133253_DOHERTY-ET-AL-1992","doi-asserted-by":"crossref","unstructured":"Doherty RA , Stubblefield P, Dostal-Johnson DA and Day GJ (1992) White blood cell immunization and anticardiolipin antibody levels in women with recurrent miscarriages. Fertil Steril58,199\u2013201.","DOI":"10.1016\/S0015-0282(16)55162-0"},{"key":"key\n\t\t\t\t20171012133253_HENTSCHEL-ET-AL-1995","doi-asserted-by":"crossref","unstructured":"Hentschel R , Broecker EB, Kolde G, Frosch M, Friedrich W, Holzgreve W, Westphal E and Harms E (1995) Intact survival with transfusion-associated graft-versus-host disease proved by human leukocyte antigen typing of lymphocytes in skin biopsy specimens. J Pediatr126,61\u201364.","DOI":"10.1016\/S0022-3476(95)70503-1"},{"key":"key\n\t\t\t\t20171012133253_HOPKINS-2000","unstructured":"Hopkins K (2000) The Basic Lymphocyte Microcytotoxicity Tests: Standard and AHG Enhancement. In Hahn A, Land G and Strothman R (eds) ASHI Laboratory Manual. American Society for Histocompatibility and Immunogenetics, Mt Laurel, NJ, USA, pp I.C.1-1-7."},{"key":"key\n\t\t\t\t20171012133253_JACOBSON-ET-AL-1997","doi-asserted-by":"crossref","unstructured":"Jacobson DL , Gange SJ, Rose NR and Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol84,223\u2013243.","DOI":"10.1006\/clin.1997.4412"},{"key":"key\n\t\t\t\t20171012133253_KARRER-ET-AL-2001","doi-asserted-by":"crossref","unstructured":"Karrer S , Holler E and Szeimies RM (2001) [Cutaneous manifestations of graft-versus-host disease]. Med Klin (Munich)96,457\u2013466.","DOI":"10.1007\/PL00002228"},{"key":"key\n\t\t\t\t20171012133253_KATZ-ET-AL-1992","doi-asserted-by":"crossref","unstructured":"Katz I , Fisch B, Amit S, Ovadia J and Tadir Y (1992) Cutaneous graft-versus-host-like reaction after paternal lymphocyte immunization for prevention of recurrent abortion. Fertil Steril57,927\u2013929.","DOI":"10.1016\/S0015-0282(16)54983-8"},{"key":"key\n\t\t\t\t20171012133253_KENNEY-ET-AL-2004","doi-asserted-by":"crossref","unstructured":"Kenney RT , Frech SA, Muenz LR, Villar CP and Glenn GM (2004) Dose sparing with intradermal injection of influenza vaccine. New Engl J Med351,2295\u20132301.","DOI":"10.1056\/NEJMoa043540"},{"key":"key\n\t\t\t\t20171012133253_KILPATRICK-1992","doi-asserted-by":"crossref","unstructured":"Kilpatrick DC (1992) Cardiolipin antibody levels are not influenced by leukocyte immunotherapy in patients experiencing recurrent spontaneous abortion. Fertil Steril57,328\u2013330.","DOI":"10.1016\/S0015-0282(16)54839-0"},{"key":"key\n\t\t\t\t20171012133253_KIPROV-ET-AL-1994","doi-asserted-by":"crossref","unstructured":"Kiprov DD , Sheppard HW and Hanson CV (1994) Alloimmunization to prevent AIDS? Science263,737\u2013738.","DOI":"10.1126\/science.8303282"},{"key":"key\n\t\t\t\t20171012133253_KLING-ET-AL-2002A","doi-asserted-by":"crossref","unstructured":"Kling C , Magez J, Jenisch S and Kabelitz D (2002) [Effect of allogeneic leukocyte immunization on consecutive IVF\/ICSI treatment for failure in the in-vitro fertilization program]. Geburtsh Frauenheilk62,661\u2013667.","DOI":"10.1055\/s-2002-33016"},{"key":"key\n\t\t\t\t20171012133253_KLING-ET-AL-2002B","doi-asserted-by":"crossref","unstructured":"Kling C , Magez J, Jenisch S and Kabelitz D (2002) Experience with allogeneic leukocyte immunization for implantation failure in the in-vitro fertilization program. Am J Reprod Immunol48,147.","DOI":"10.1034\/j.1600-0897.2002.00007.x"},{"key":"key\n\t\t\t\t20171012133253_LAM-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"Lam GK , Subramanyam L, Orton S, Farb R and Moise KJ Jr (2003) Minimizing red blood cell contamination while isolating mononuclear cells from whole blood: the next step for the treatment of severe hemolytic disease of the fetus\/newborn. Am J Obstet Gynecol189,1012\u20131016.","DOI":"10.1067\/S0002-9378(03)00813-5"},{"key":"key\n\t\t\t\t20171012133253_LAU-AND-SISSON-2002","doi-asserted-by":"crossref","unstructured":"Lau C and Sisson J (2002) The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J Travel Med9,285\u2013288.","DOI":"10.2310\/7060.2002.30088"},{"key":"key\n\t\t\t\t20171012133253_LINDQVIST-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Lindqvist P , Dahlback B and Marsal K (1999) Thrombotic risk during pregnancy: a population study. Obstet Gynecol94,595\u2013599.","DOI":"10.1097\/00006250-199910000-00021"},{"key":"key\n\t\t\t\t20171012133253_MCLELLAN-ET-AL-1998","doi-asserted-by":"crossref","unstructured":"McLellan AD , Heiser A, Sorg RV, Fearnley DB and Hart DN (1998) Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype. J Invest Dermatol111,841\u2013849.","DOI":"10.1046\/j.1523-1747.1998.00375.x"},{"key":"key\n\t\t\t\t20171012133253_MONCAYO-ET-AL-1990","doi-asserted-by":"crossref","unstructured":"Moncayo R , Moncayo H, Steffens U, Soelder E, Kersting A and Dapunt O (1990) Serum levels of anticardiolipin antibodies are pathologically increased after active immunization of patients with recurrent spontaneous abortion. Fertil Steril54,619\u2013623.","DOI":"10.1016\/S0015-0282(16)53818-7"},{"key":"key\n\t\t\t\t20171012133253_NELSON-2001","doi-asserted-by":"crossref","unstructured":"Nelson JL (2001) HLA relationships of pregnancy, microchimerism and autoimmune disease. J Reprod Immunol52,77\u201384.","DOI":"10.1016\/S0165-0378(01)00116-4"},{"key":"key\n\t\t\t\t20171012133253_NEPPERT-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Neppert J , Witzleben-Schurholz E, Zupanska B, Bartz L, Greve O, Eichler H, Kerowgan M and Wichmann MG (1999) High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the Study of Protective Maternal HLA Antibodies in the Clinical Course of HDN. Eur J Haematol63,120\u2013125.","DOI":"10.1111\/j.1600-0609.1999.tb01125.x"},{"key":"key\n\t\t\t\t20171012133253_OBER-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Ober C , Karrison T, Odem RR, Barnes RB, Branch DW, Stephenson MD, Baron B, Walker MA, Scott JR and Schreiber JR (1999) Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet354,365\u2013369.","DOI":"10.1016\/S0140-6736(98)12055-X"},{"key":"key\n\t\t\t\t20171012133253_POULSEN-ET-AL-1994","doi-asserted-by":"crossref","unstructured":"Poulsen LO , Tage-Jensen U, Christiansen OB, Grunnet N and Vyberg M (1994) Autoimmune hepatitis associated with allogeneic lymphocyte immunisation. J Hepatol21,1149.","DOI":"10.1016\/S0168-8278(05)80638-5"},{"key":"key\n\t\t\t\t20171012133253_PRIGOSHIN-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Prigoshin N , Tambutti ML, Redal MA, Gorgorza S, Lancuba SM, Nicholson R and Testa R (1999) Microchimerism and blocking activity in women with recurrent spontaneous abortion (RSA) after alloimmunization with the partner\u2019s lymphocytes. J Reprod Immunol44,41\u201354.","DOI":"10.1016\/S0165-0378(99)00021-2"},{"key":"key\n\t\t\t\t20171012133253_QUAYLE-ET-AL-2004","doi-asserted-by":"crossref","unstructured":"Quayle AJ , Fidel P, Jr and Rosenberg ES (2004) Sex, alloimmunisation, and susceptibility to HIV infection. Lancet363,503\u2013504.","DOI":"10.1016\/S0140-6736(04)15575-X"},{"key":"key\n\t\t\t\t20171012133253_RMITG-1994","doi-asserted-by":"crossref","unstructured":"Recurrent Miscarriage Immunotherapy Trialists Group (1994) Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Am J Reprod Immunol32,55\u201372.","DOI":"10.1111\/j.1600-0897.1994.tb01095.x"},{"key":"key\n\t\t\t\t20171012133253_REGAN-ET-AL-1991","doi-asserted-by":"crossref","unstructured":"Regan L , Braude PR and Hill DP (1991) A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod6,294\u2013298.","DOI":"10.1093\/oxfordjournals.humrep.a137325"},{"key":"key\n\t\t\t\t20171012133253_RIVEY-AND-PETERSON-1991","doi-asserted-by":"crossref","unstructured":"Rivey MP and Peterson J (1991) Intradermal hepatitis B vaccination. Drug Intelligence and Clinical Pharmacy (DICP)\/Annals of Pharmacotheraphy25,628\u2013634.","DOI":"10.1177\/106002809102500612"},{"key":"key\n\t\t\t\t20171012133253_SCOTT-2000","unstructured":"Scott JR (2000) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev, CD000112."},{"key":"key\n\t\t\t\t20171012133253_SHEARER-ET-AL-1999","doi-asserted-by":"crossref","unstructured":"Shearer GM , Pinto LA and Clerici M (1999) Alloimmunization for immune-based therapy and vaccine design against HIV\/AIDS. Immunol Today20,66\u201371.","DOI":"10.1016\/S0167-5699(98)01392-9"},{"key":"key\n\t\t\t\t20171012133253_TAYLOR-AND-FAULK-1981","doi-asserted-by":"crossref","unstructured":"Taylor C and Faulk WP (1981) Prevention of recurrent abortion with leucocyte transfusions. Lancet2,68\u201370.","DOI":"10.1016\/S0140-6736(81)90413-X"},{"key":"key\n\t\t\t\t20171012133253_VANDERMAST-ET-AL-2003","doi-asserted-by":"crossref","unstructured":"van der Mast BJ , van den Dorpel MA, Drabbels JJ, Claas FH and Weimar W (2003) Transfusion-associated graft versus host disease after donor-specific leukocyte transfusion before kidney transplantation. Clin Transplant17,477\u2013483.","DOI":"10.1034\/j.1399-0012.2003.00074.x"},{"key":"key\n\t\t\t\t20171012133253_ZHOU-ET-AL-2003","unstructured":"Zhou W , Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS et al (2003) Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001. MMWR Surveill Summ52,1\u201324."}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/21\/2\/429\/1691726\/dei316.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:55:56Z","timestamp":1586498156000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/21\/2\/429\/613981\/Adverse-effects-of-intradermal-allogeneic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,6]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,10,6]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei316","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,10,6]]}}}